Pagnon, A., Piras, F., Gimenez-Fourage, S., Dubayle, J., Arnaud-Barbe, N., Hessler, C., & Caillet, C. (2017). Optimized enzyme-linked immunosorbent assay for detecting cytomegalovirus infections during clinical trials of recombinant vaccines. Journal of clinical virology, 96, 99-104. https://doi.org/10.1016/j.jcv.2017.10.004
Chicago Style (17th ed.) CitationPagnon, Anke, Fabienne Piras, Sophie Gimenez-Fourage, Joseline Dubayle, Nadège Arnaud-Barbe, Catherine Hessler, and Catherine Caillet. "Optimized Enzyme-linked Immunosorbent Assay for Detecting Cytomegalovirus Infections During Clinical Trials of Recombinant Vaccines." Journal of Clinical Virology 96 (2017): 99-104. https://doi.org/10.1016/j.jcv.2017.10.004.
MLA (9th ed.) CitationPagnon, Anke, et al. "Optimized Enzyme-linked Immunosorbent Assay for Detecting Cytomegalovirus Infections During Clinical Trials of Recombinant Vaccines." Journal of Clinical Virology, vol. 96, 2017, pp. 99-104, https://doi.org/10.1016/j.jcv.2017.10.004.